SpaceX Starship Test Flight Scrubbed Friday Retry Planned IPO Prospectus Released Alibaba Unveils Advanced Zhenwu AI Chip and New Large Language Model Artha Venture Funds EarlyStage Strategy Spotting Winnable Ideas Before Market Readiness Singapore Regulator Targets Faster Private Banking Account Opening for Wealthy Clients FedExLed Consortium Set to Open 9 Billion Buyout Window for Polish Parcel Firm InPost in Late May Devon Energy Invests 26 Billion to Expand Delaware Basin Presence PHUN Q1 2026 Earnings EPS Beats Estimates Amid Limited Revenue Disclosure CRCT Q1 2026 Earnings EPS Surges Past Estimates with 145 Beat NU Q1 2026 Earnings EPS Misses Estimates Amid Rising Provision Costs Nordson Q1 2026 Earnings Narrow EPS Miss Fails to Derail Investor Confidence Largo Inc LGO Q1 2026 Earnings Narrower Loss Reported Amid Quiet Market Reaction CRWD Q1 2026 Earnings EPS Slightly Misses Estimates Stock Drops 39 Westin Acquisition Corp WSTN Holds Steady at 1008 Amid Quiet Trading Biodesix BDSX Hovers Near Support as Slight Decline Tests Key Levels Lennox International LII Edges Higher as HVAC Demand Stabilizes MLACR Holds Steady at 023 With Minimal Price Movement iRadimed Corporation IRMD Holds Steady Near Key Support A Technical and Fundamental Review Japanese Snack Maker Behind Shiruko Sand Eyes Singapore and Southeast Asia for Expansion DYAI Q1 2026 Earnings EPS Misses Mark as PreRevenue Biotech Maintains Pipeline Focus CapsoVision Inc CV Advances 118 as Price Moves Toward Resistance DT Q1 2026 Earnings EPS Surpasses Estimates by 237 Stock Declines Slightly DouYu Q4 2025 Earnings EPS Surges Past Estimates Despite Revenue Disclosures TNDM Q1 2026 Earnings BetterThanExpected Losses but Revenue Details Missing Equitable Holdings Inc EQH Q1 2026 Earnings Marginal EPS Miss as Stock Edges Higher Hillman Solutions Corp HLMN Q1 2026 Earnings EPS Misses Estimates as Operational Costs Weigh on Results AP Q4 2025 Earnings Net Loss Reported as Company Navigates Challenging Conditions CMMB Q1 2026 Earnings EPS Misses Estimates as DevelopmentStage Biotech Continues Without Revenue